![Currie Gavin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Currie Gavin
Oprichter bij Biosceptre (Aust) Pty Ltd.
Profiel
Currie Gavin is the founder of Biosceptre (Aust) Pty Ltd.
He currently works as a Director at Prescare.
Previously, he worked as the Chief Executive Officer & Director at Biosceptre International Ltd.
Actieve functies van Currie Gavin
Bedrijven | Functie | Begin |
---|---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Oprichter | - |
Prescare
![]() Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Currie Gavin
Bedrijven | Functie | Einde |
---|---|---|
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Health Technology |
Prescare
![]() Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia. | Commercial Services |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Health Technology |